안국약품

001540KOSDAQ의약품 제조업

65.3 / 100

Reference Date: 2026-07-24

Financial Score16.5 / 40

News Sentiment18.8 / 25

Momentum20.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE is above the industry average but the high debt ratio poses financial risk. Surged 19.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

AnKook Pharmaceuticals, established in 1959, is a company specializing in the production and sale of pharmaceuticals and health functional foods, with key products including Sinechura and Levotension. In 2022, sales increased by 16% year-on-year to 271.1 billion KRW, and operating profit rose 32.4% to 6.7 billion KRW, driven by strong market share in respiratory and circulatory drug segments. The company is expanding into AI medical devices and online sales through 'Ewonther' to diversify its business.

Number of Employees

424people

Average Salary

58.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

17.83Industry Average 11.231.5Point

1.6x industry avg (risky)

PBR

0.92Industry Average 0.812.5Point

Higher than industry avg (caution)

ROE

4.42Industry Average 4.014.0Point

In line with industry avg

Debt Ratio

37.13Industry Average 12.430.0Point

3.0x industry avg (risky)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲14.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲39.5% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 5.1% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 2Neutral 1Negative 0Average Sentiment Score 75

Neutral
"준법경영 의식 내재화"…안국약품, 임직원 강연
안국약품이 컴플라이언스 교육을 통해 윤리 의식을 강화하려는 노력을 보였지만, 직접적인 재무 성과나 시장 영향은 제한적입니다.
Positive
"치료옵션 확대"…안국약품, 고혈압 치료제 출시
안국약품의 새로운 고혈압 치료제 출시로 CV 시장에서의 경쟁력 강화 및 매출 증대 기대.
Positive
"환경·안전보건 정착"…안국, ISO 사후심사 통과
안국약품이 ISO14001 및 45001 인증 사후심사를 통과하여 환경 및 안전 관리 체계 강화로 긍정적인 평가를 받음.

Detailed Momentum

52-week position8.0Point

Near 52w high (91%, uptrend)

Current 11,730Won52-week high 12,13052-week low 7,280

1-month return6.0Point

1m +19.82% (strong rise)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral신규시설투자등2026-07-14
Neutral주식등의대량보유상황보고서(일반)2026-06-30